Most Read News

EBITDA increased by 3% to ₹47.8 Crore in the second quarter of this fiscal year, up from ₹46.4 Crore in the same period last year.

On the last day of bidding, which was dominated by retail buyers, Sagility India's IPO was subscribed for 3.2 times.

The company observed reduced staff expenses and regulatory contributions, as well as a significant 14% quarter-on-quarter (QoQ) decrease.

The new factory will use a proprietary technology that combines carbon dioxide extracted from energy generation emissions.

Notably, more than 25% of these orders came from the EV segment, demonstrating the company's commitment to EV market growth.

The cosmetics company reported a profit of ₹5.85 Crore in the same quarter previous year. On a quarterly basis, net profit increased 4.1%.

According to the Chief Minister, the company will invest ₹130 Crore per CBG facility, creating an estimated 2.5 lakh jobs.

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and 7.5 mg dosages.

The project is expected to take three years to complete, and the corporation will earn a 10-year maintenance contract for it.

On November 12, the indices shred earlier gains and closed negative amid selling across sectors.